Greenleaf Peter Insider Trading Activity

Average Profitability
37.58%
Insider Buys Quantity
2
Insider Buys Sum
$159,532.14
Insider Sells Quantity
5
Insider Sells Sum
$3.98M

Insider Activity of Greenleaf Peter

Biography of Greenleaf Peter

No biography is available at this moment.

2025-03-04SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
164,947
0.1174%
$7.92$1.31M+44.55%
2025-03-03SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
195,593
0.1432%
$8.00$1.56M+45.61%
2024-03-06SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
126,981
0.0894%
$5.60$711,094+22.37%
2023-03-02SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
33,047
0.0228%
$8.78$290,153+2.57%
2022-03-02SaleAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
9,068
0.0066%
$12.01$108,907-27.71%
2021-05-11PurchaseAurinia Pharmaceuticals Inc.
AUPH
Chief Executive Officer
10,250
0.0076%
$10.71$109,782+37.58%
2018-05-18PurchaseAvalo Therapeutics, Inc.
AVTX
Chief Executive Officer
12,500
0.0091%
$3.98$49,750+17.39%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.